Learn More
BD CompBead Anti-Mouse Ig, κ/Negative Control Particles Set
Used to optimize fluorescence compensation settings for multicolor flow cytometric analyses. BD™ Anti-Mouse Ig, κ/Negative Control Particles Set includes two sets of polystyrene microparticles to distinctly stain positive and negative populations, especially when using tandem dye conjugates.
Supplier: BD 552843
Description
The set provides two populations of microparticles:
- BD™ CompBeads Anti-Mouse Ig, κ—Binds any mouse κ light chain-bearing immunoglobulin
- BD™ CompBeads Negative Control—Has no binding capacity
When mixed together with a fluorochrome-conjugated mouse antibody, the CompBeads provide distinct positive and negative (background fluorescence) stained populations which can be used to set compensation levels manually or using instrument set-up software.
Since the compensation adjustments are made using the same fluorochrome-labeled antibody to be used in the experiment, this method allows the investigator to more accurately establish compensation corrections for spectral overlap for any combination of fluorochrome-labeled antibodies (without having to use valuable tissue samples or hard-dyed beads with potentially mismatched fluorescence spectra).
Use of the BD™ CompBeads is highly recommended for use in all experiments using tandem dye (i.e., PE-Cy™7, APC-Cy™7, etc.) conjugates, which may have distinct spectral characteristics for each conjugate.
Specifications
Mouse Ig, κ | |
Unconjugated | |
Unpurified | |
Primary | |
Liquid |
Flow Cytometry | |
CompBead Anti-Mouse Ig, kappa Particles CompBead Negative Control (FBS) Compensation Particles |
|
6 mL Each | |
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.